The Pharmaceutical Industry and The Process of Drug Discovery What is a Drug? Types of Pharmaceutical Products What are the Important Disease Targets? How the Industry Has Evolved Drug Discovery and The Process of Getting a Drug to Market - an overview
26
Embed
Introduction to the Pharmaceutical · PPT file · Web view · 2011-02-10The Pharmaceutical Industry and The Process of Drug Discovery. What is a Drug? Types of...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
The Pharmaceutical Industry and The Process of Drug Discovery
What is a Drug? Types of Pharmaceutical Products What are the Important Disease Targets? How the Industry Has Evolved Drug Discovery and The Process of Getting
a Drug to Market - an overview
What is a drug?
“A Chemical Substance that Interacts with a Living System and Produces a Biological Response”
What is a drug?
“A Chemical Substance that Interacts with a Living System and Produces a Biological Response”
O
CO2H
Me
O
NH
NN
N
OEt
SN
O O
MeO
MeN
Good and Bad Drugs?
Safe Drugs?
What is a drug?
“A Chemical Substance that Interacts with a Living System and Produces a Biological Response”
Good and Bad Drugs?
Safe Drugs?
What is a drug?
“A Chemical Substance that Interacts with a Living System and Produces a Biological Response”
Morphine (bad?) vs. penicillin (good?)
Curare vs. paracetamol
Classification of Drug Types
Ethical drugs
Generic drugs (no longer under patent)
“Prescription Only” vs “Over the Counter” “Off Label” applications Orphan drugs Biotechnology products Counterfeit drugs Street drugs!
What criteria MUST new drugs meet?
Drugs must address a new need or provide a significant “added benefit” over an existing medicine
Drugs must also meet five criteria: Must be safe, effective, of high quality …cost effective (1980s) ……….affordable (1990s) ……………REALLY affordable (2000+)
Treatment of metabolic disorders (1960’s to current day) Ventolin (1969), Lipitor (1997), Viagra (1998), Avandia (1999), Vioxx
(1999), Gleevec (2001) Search for gene therapies (1990), stem cell-based therapies Stem-cell replacement of a trachea (2008)
Some Important Events American Civil War Legislation – UK Cruelty to Animals Act (1876); US Federal Food
and Drug Act (1906) World War 1 - Development of UK regulatory rules World War 2 – antibiotics Vaccines – Smallpox: Jenner (1796) – eradicated in 1977 Thalidomide (1960) – report adverse drug reactions AIDS (1980s) – fast track approval, “buyer power” Viagra (1998) Tamiflu – H1N1 (swine flu) pandemic (2009) NICE (1999) – the affordability factor Vioxx – anti-inflammatory – 1999-2004 due to litigation Avandia – Type 2 (non-insulin dependent) diabetes - 1999-2010
also due to litigation
How do drugs work?
The Biological Target - enzyme or receptor
Where is the target - part of “us” or elsewhere
Paul Ehrlich, Nobel Prize 1908, salvarsan; blood-brain barrier; “Lock and Key”
Here the KEY is the natural substrate Binding of the KEY to the LOCK (an enzyme
or a receptor) then causes a response – a shape change in the protein/receptor
The “Lock and Key” analogy
LockKey
Binding Biological Response
Here the KEY is the natural substrate Binding of the KEY to the LOCK (an enzyme
or a receptor) then causes a response – a shape change in the protein/receptor
Binding of Drugis preferred
vs.
Biological responseis altered OR shut down
But when an effective drug is present
Drug may bind preferentially to the “active site” Antagonist – binds and BLOCKS Agonist – binds and ACTIVATES Partial agonist – induces a partial response
toxicology Formulation - pharmaceutical sciences Clinical evaluation – medicine Manufacture - chemical engineering
Getting a drug to market
Disease target - possible drug candidates Pre-clinical testing; R&D (1-3 yrs)
Toxicology, “ADME” Clinical R&D (2-10 yrs; Av. 5yrs)
Phase 1 – healthy volunteers Phase 2 – small patient group Phase 3 – larger patient group
Regulatory approval (2-10(!) yrs) Market Phase 4 – long term monitoring
The Gamble - wastage and timescale
For EACH DRUG approved, an average of 7500
compounds will have been made
Of this 7500, an average of 21 will be tested for
subacute toxicology, 6.5 will be tested in humans and
2.5 will reach Phase 3 – 1 then gets to market………
Entire process takes on average 12 years Costs $138M (1975); $800M (2000); $1.6Bn (2008) Development costs do NOT include pre-launch
marketing which can DOUBLE costs
The “Pay Off”……to the companies
Typical R&D budget: 33% R and 67%D R&D = 15 to 25 % of sales turnover Patent protection – 20 years from filing On average, 11yrs. of productive market life Losec – $2.7Bn in 1998; Nexium (single
enantiomer) $7.7Bn in 2008 Lipitor - $1Bn in 1998; $13.8Bn in 2008
The “Pay Off”…….to us Massive contributions to health, quality of life,
reduced child mortality, life expectancy Vaccines have eradicated major disease –
smallpox; vaccines for malaria and pneumonia soon……..?
But costs and accessibility to healthcare are becoming major social and geopolitical issues
And, is there something seedy about making money out of illness?
What makes a good drug?Lipinski's rules (Chris Lipinski – 1997)
In general, an orally active drug will meet most of the following:
• Not more than 5 hydrogen bond donors (nitrogen or oxygen atoms with one or more hydrogen atoms)
• Not more than 10 hydrogen bond acceptors (nitrogen or oxygen atoms)
• A molecular weight under 500 daltons • An octanol-water partition coefficient log P of less than 5 • http://www.molinspiration.com/cgi-bin/properties
Case Study Cimetidine (Tagamet)
1964
1966
1968
1970
1972
1974
1976
1979
First lead
Burimamide
Cimetidine
Into volunteers
UK US
Programme starts
H2 blocker; anti-ulcer/heartburn
1983 First drug to reach $1Bn Cleared for OTC in 1995
What is a drug?
“A Chemical Substance that Interacts with a Living System and Produces a Biological Response”